Vendome Acquisition Corp I
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
VNME$10.35+0.3%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Balance Sheet as of June 30, 2025
BALANCE SHEET
JUNE 30, 2025
| ASSETS | |
|---|---|
| Current Assets: | |
| Cash | $73,592 |
| Total Current Assets | 73,592 |
| Deferred offering costs | 884,292 |
| Total Assets | $957,884 |
| LIABILITIES AND SHAREHOLDER’S EQUITY | |
| Current Liabilities: | |
| Accrued offering costs | $632,884 |
| Related Party Payable | 300,000 |
| Total Current Liabilities | 932,884 |
| Commitments and contingencies (Note 6) | |
| Shareholder’s Equity: | |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | — |
| Class A ordinary shares, $0.0001 par value, 200,000,000 shares authorized, none issued and outstanding | — |
| Class B ordinary shares, $0.0001 par value, 20,000,000 shares authorized, 5,750,000 shares issued and outstanding(1)(2) | 575 |
| Additional paid-in capital | 24,425 |
| Retained earnings | — |
| Total Shareholder’s Equity | 25,000 |
| Total Liabilities and Shareholder’s Equity | $957,884 |
| (1) | Includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). |
| (2) | Shares and associated accounts have been retroactively restated to reflect the surrender of 5,544,643 Class B ordinary shares to the Company for no consideration on March 25, 2025. On May 25, 2025, the Company issued to the Sponsor, for no consideration, an aggregate of 1,437,500 founder shares. Shares and associated accounts have been retroactively restated to reflect the issuance of 1,437,500 Class B ordinary shares to the Sponsor for no consideration on May 25, 2025 (see Note 5). |
CONDENSED STATEMENTS OFOPERATIONS
| For the three months ended June 30, 2025 | For the period from January 28, 2025 (inception) through June 30, 2025 | |
|---|---|---|
| Formation and operating expenses | $— | $— |
| Total Expenses | — | — |
| Net loss | $— | $— |
| Weighted average ordinary shares outstanding basic and diluted(1)(2) | 5,000,000 | 3,922,078 |
| Basic and diluted net loss per ordinary share | $(0.00) | $(0.00) |
| (1) | Excludes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). |
| (2) | Shares and associated accounts have been retroactively restated to reflect the surrender of 5,544,643 Class B ordinary shares to the Company for no consideration on March 25, 2025. On May 25, 2025, the Company issued to the Sponsor, for no consideration, an aggregate of 1,437,500 founder shares. Shares and associated accounts have been retroactively restated to reflect the issuance of 1,437,500 Class B ordinary shares to the Sponsor for no consideration on May 25, 2025 (see Note 5). |
CONDENSED STATEMENTS OF CHANGES INSHAREHOLDER’S EQUITY
FOR THE PERIOD FROM JANUARY 28, 2025 (INCEPTION) THROUGH
JUNE 30, 2025 AND FOR THE THREE MONTHS ENDED JUNE 30, 2025
| Class B Ordinary Shares · Additional Paid-In Capital · Retained Earnings · Shareholder’s Equity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||||
| Balance, January 28, 2025 (inception) | — | $— | $— | $— | $— | ||||
| Issuance of Class B ordinary shares to Sponsor(1)(2) | 5,750,000 | 575 | 24,425 | — | 25,000 | ||||
| Balance, March 31, 2025 | 5,750,000 | 575 | 24,425 | — | 25,000 | ||||
| Net loss | - | - | - | - | - | ||||
| Balance, June 30, 2025 | 5,750,000 | $575 | $24,425 | $ | - | $25,000 | |||
| (1) | Includes an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). |
| (2) | Shares and associated accounts have been retroactively restated to reflect the surrender of 5,544,643 Class B ordinary shares to the Company for no consideration on March 25, 2025. On May 25, 2025, the Company issued to the Sponsor, for no consideration, an aggregate of 1,437,500 founder shares. Shares and associated accounts have been retroactively restated to reflect the issuance of 1,437,500 Class B ordinary shares to the Sponsor for no consideration on May 25, 2025 (see Note 5). |
CONDENSED STATEMENT OF
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.